Lead by a senior research fellow from University of Sydney, HWL is conducting research in alternative regenerative medicines. Majority of its projects are in the field of Stem Cells. With a target turnover of $50 million next year, this company has achieved enormous growth in its short time span by ...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2011 (13 years) |
Funding status Private |
Company type SME |